Evidence map›Paper›PMID 35508046›Full record

ArticleArquivos brasileiros de cardiologia2022

Mortality from Heart Failure with Mid-Range Ejection Fraction.

Giovanni Possamai Dutra, Bruno Ferraz de Oliveira Gomes, Plínio Resende do Carmo Júnior, João Luiz Fernandes Petriz, Emilia Matos Nascimento, Basilio de Bragança Pereira, Gláucia Maria Moraes de Oliveira

Open access · diamondAbstract read
In one paragraph

Article in Arquivos brasileiros de cardiologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Giovanni Possamai DutraUniversidade Federal do Rio de Janeiro, Rio de Janeiro, RJ - Brasil.ORCID 0000-0001-7668-4224
Bruno Ferraz de Oliveira GomesUniversidade Federal do Rio de Janeiro, Rio de Janeiro, RJ - Brasil.ORCID 0000-0001-7443-7270
Plínio Resende do Carmo JúniorUniversidade Federal do Rio de Janeiro, Rio de Janeiro, RJ - Brasil.ORCID 0000-0001-7869-8128
João Luiz Fernandes PetrizHospital Barra D'or - Cardiologia, Rio de Janeiro, RJ - Brasil.ORCID 0000-0003-4598-5512
Emilia Matos NascimentoCentro Universitário Estadual da Zona Oeste - UEZO, Rio de Janeiro, RJ - Brasil.ORCID 0000-0001-8313-8766
Basilio de Bragança PereiraUniversidade Federal do Rio de Janeiro, Rio de Janeiro, RJ - Brasil.ORCID 0000-0003-3098-092X
Gláucia Maria Moraes de OliveiraUniversidade Federal do Rio de Janeiro, Rio de Janeiro, RJ - Brasil.ORCID 0000-0002-0737-6188
Universidade Federal do Rio de Janeiro · BRD’Or Institute for Research and Education · BRUniversidade Estadual da Zona Oeste · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prognostic importance of the classification 'heart failure (HF) with mid-range ejection fraction (EF)' remains uncertain.

objectiveTo analyze the clinical characteristics, comorbidities, complications, and in-hospital and late mortality of patients classified as having HF with mid-range EF (HFmrEF - EF: 40%-49%), and to compare them to those of patients with HF with preserved EF (HFpEF - EF > 50%) and with HF with reduced EF (HFrEF - EF < 40%) on admission for decompensated HF.

methodsAmbispective cohort of patients admitted to the cardiac intensive care unit due to decompensated HF. Clinical characteristics, comorbidities, complications, and in-hospital and late mortality were assessed. The software R was used, with a 5% significance, for the tests chi-square, analysis of variance, Cox multivariate, and Kaplan-Meier survival curve, in addition to machine-learning techniques (Elastic Net and survival tree).

results519 individuals were included between September 2011 and June 2019 (mean age, 74.87 ± 13.56 years; 57.6% were men). The frequencies of HFpEF, HFmrEF and HFrEF were 25.4%, 27% and 47.6%, respectively. Previous infarction was more frequent in HFmrEF. The mean follow-up time was 2.94 ± 2.55 years, with no statistical difference in mortality between the groups (53.8%, 52.1%, 57.9%). In the survival curve, there was difference between neither the HFpEF and HFmrEF groups, nor the HFpEF and HFrEF groups, but between the HFmrEF and HFrEF groups. Age over 77 years, previous HF, history of readmission, dementia and need for vasopressors were associated with higher late mortality in the survival tree.

conclusionThe EF was not selected as a variable associated with mortality in patients with decompensated HF.

Indexed as

Heart FailureAgedAged, 80 and overFemaleHospitalizationHumansMaleMiddle AgedPrognosisRegistriesStroke VolumeVentricular Function, Left

Identifiers

PMID35508046
PMCPMC9007002
OpenAlexW4223514529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.